Smoking, a leading cause of chronic diseases, is often used to cope with stress, which has been heightened by the pandemic due to health and economic concerns. Studies have shown that the Big Five personality traits are linked to smoking behavior, suggesting that different personality traits influence nicotine use in varying ways. However, there remains a significant gap in understanding how individuals with different personalities respond to nicotine use under stress. This study aims to investigate how nicotine dependence changes for different Big Five personalities under the pandemic stress and whether other stress-related factors influence nicotine dependence during COVID-19. This cross-sectional study collect data from randomly selected adults aged 18-30 in the US. The Big Five Personality Model assessed personality traits, and nicotine dependence was measured with the Hooked-on Nicotine Checklist. Stress was evaluated using the Perceived Stress Scale, while demographics and other pandemic-related stressors were gathered through structured questions. Correlation and multiple logistic regression models were used for data analysis. The main findings showed that both before (r = −.25, p < .001) and during (r = −.19, p < .001) the pandemic, agreeableness was significantly negatively associated with nicotine dependence, indicating that higher agreeableness was linked to lower nicotine dependence. Similarly, conscientiousness was negatively correlated with nicotine dependence both before (r = −.123, p < .001) and during COVID-19 (r = −.19, p < .001). Although no direct association was found between perceived stress, personality traits, and smoking behavior, the analysis identified that external stressors played a moderating role. These findings emphasize the importance of understanding how different personality traits influence young people’s dependence on nicotine under stress. The outcome can guide the design of targeted nicotine withdrawal interventions and inform effective public health strategies.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of Southern California Institutional Review Board is the institutional review board or ethics committee that approved the study. UP-23-01234 is the approval number and/or a statement indicating approval of this research. This study do not have consent since this study is exempt review.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data cannot be shared publicly because of consent agreement. Data are available from the University of Southern California Institutional Review Board for researchers who meet the criteria for access to confidential data.